does tirzepatide cause bone loss Study: Weight Drugs Like Ozempic Could Trigger Loss Frontiers | Bone mineral density

Semaglutide shows potential in managing chronic skin condition in people with obesity A groundbreaking study presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024 has highlighted the promising role of semaglutide in treating hidradenitis suppurativa (HS), a chronic skin condition that frequently affects individuals living with obesity

PMID: 23845841

Biobank self-reported ME/CFS patients approximated the h 2 to be 0.08 with a low confidence (72)

If you hit muscle (deeper injection), you may experience sharp pain

Pham P, Sarkar M, Pham P, Pham P

With living comes aging and the human condition exists in a Catch 22 of sorts